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Objective: This study was performed to correlate the changes in concentration of S-100 pro-
tein in the cerebrospinal fluid (CSF) during and after thoracoabdominal aortic aneurysm
(TAAA) surgery with the results of somatosensory and motor evoked potential monitoring.
Methods: The study was designed as a prospective study at St Antonius Hospital in
Nieuwegein, The Netherlands. The participants were 19 patients who were undergoing
elective TAAA surgery. CSF samples for analysis of S-100 protein were drawn after the
induction of anesthesia, during the cross-clamp period of the critical aortic segment,
after 5 minutes of reperfusion of this segment, during the closure of the skin, and 24
hours after the closure of the skin. In all the patients, continuous intraoperative record-
ing of myogenic motor potentials evoked by transcranial electrical stimulation (tcMEP)
and somatosensory potentials evoked by stimulation of the posterior tibial nerve took
place to monitor the integrity of the spinal cord. The operative technique consisted of
staged or sequential clamping to maximize the beneficial effect of the distal perfusion by
the left heart bypass, continuous CSF drainage to keep the CSF pressure below 10 mm
Hg, and moderate hypothermia (32°C rectal temperature). We correlated the measured
concentrations of S-100 protein in CSF with the results of evoked potential monitoring
during surgery and the number of intercostals reimplanted and oversewn.
Results: In all the patients, the concentration of S-100 protein was increased in CSF. The
highest concentration of S-100 protein was found in the CSF sample taken 5 minutes after
reperfusion of the critical aortic segment. There was a good (negative) correlation between
the changes in S-100 protein in CSF and the changes in motor evoked potential monitor-
ing during the cross-clamp period. The best (negative) correlation was detected between
the S-100 protein elevation in the CSF sample drawn 5 minutes after reperfusion and the
tcMEP amplitude reduction during clamping (r = –0.73; P = .007). No relation was found
between the S-100 protein dynamics in CSF and somatosensory evoked potential moni-
toring. A positive (r = 0.58; P = .05) correlation was found between the change in tcMEP
amplitude during clamping and the number of reattached intercostals. A moderate to good
(r = –0.5 to –0.7; P < .05) correlation between the number of reattached intercostals and
the changes in S-100 protein concentration in CSF during TAAA surgery was found. Our
data show that transient elevations in S-100 protein after cross clamping are larger in those
patients with marked decrease in tcMEP from baseline during the cross-clamp period.
Conclusion: A correlation is shown between an increasing concentration of S-100 pro-
tein in CSF and a reduction in tcMEP amplitude during cross clamping of the aorta. The
S-100 protein in CSF seems to be a marker of potential clinical value in the evaluation
of the effects of procedures to detect and reduce spinal cord ischemia. (J Vasc Surg
1999;30:293-300.)
293
From the Department of Anesthesiology and Intensive Care (Dr
van Dongen, ter Beek, and Aarts), the Department of Clinical
Neurophysiology (Dr Boezeman), the Department of
Cardiothoracic Surgery (Dr Schepens and Morshuis), and the
Department of Clinical Chemistry (Dr Haas), St Antonius
Hospital, and the Department of Pharmaco-epidemiology and
Pharmacotherapy (Dr de Boer), University of Utrecht.
Reprint requests: Dr Eric P. van Dongen, Department of
Anesthesiology and Intensive Care, St Antonius Hospital,
Koekoekslaan1, 3435 CM Nieuwegein, The Netherlands.
Copyright © 1999 by the Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/99/$8.00 + 0 24/1/99311
Paraparesis and paraplegia may result after opera-
tion for thoracoabdominal aortic aneurysms (TAAA).
The incidence of spinal cord ischemic injury ranges
from 4% to more than 40%.1,2 Current strategies to
protect the spinal cord, such as cerebrospinal fluid
(CSF) drainage, moderate hypothermia, and mainte-
nance of distal aortic perfusion with the left heart
bypass, combined with staged clamping seem to
reduce spinal cord ischemia during the cross-clamp
period. Furthermore, the use of motor evoked
potential (MEP) and somatosensory evoked poten-
tial (SEP) recording during TAAA surgery is advo-
cated by some authors3-5 to identify segmental arter-
ies that supply the spinal cord and to monitor the
neurophysiologic effects of reperfusion of those crit-
ical segmental arteries.
An ischemic insult of sufficient magnitude and
duration will produce irreversible spinal cord injury.
It has been shown that S-100 protein is released dur-
ing acute damage of the central nervous system,
such as spinal cord ischemia.6-8 This protein is a
member of the S-100 family of calcium binding pro-
teins and is found in high concentrations in glial and
Schwann cells.9-11 S-100 protein in serum could be
a predictor of an adverse outcome, as shown after
cardiac surgery.10-12
The aim of this study was first to evaluate the ini-
tial clinical experience in determining the concentra-
tion of S-100 protein in CSF during and 24 hours
after TAAA surgery and to correlate the changes in
concentration to the results of MEP recording and
SEP recording, respectively. Secondly, the influence
of the number of reattached intercostals on the
changes in S-100 protein concentration and evoked
potential responses was determined.
PATIENTS AND METHODS
Nineteen patients (three women, aged 63 to 75
years, and 16 men, aged 37 to 81 years) who under-
went surgery on the thoracoabdominal aorta (type II
Crawford classification) were studied. There were no
dissections in the patients who were included. Before
surgery, all the patients were free from any neuromus-
cular disorder. The experimental procedure was
approved by the Institutional Ethics Committee, and
written informed consent was obtained from all the
patients who were scheduled to undergo TAAA repair.
Anesthetic technique. The patients were
administered premedication with 10 mg of mor-
phine and 5 mg of haloperidol intramuscularly 1
hour before surgery. After venous cannulation of the
right arm and cannulation of the right radial artery,
anesthesia was induced with diazepam (0.2 to 0.3
mg·kg-1), fentanyl citrate (20 to 30 m g·kg-1), and
low dose propofol infusion aimed at a plasma steady
state concentration of 1 m g·mL-1 (150 to 200
mg·hour-1). Tracheal intubation (left-sided double
lumen tube) was performed. If necessary, 20 mg of
succinyl choline was given intravenously to facilitate
intubation. The position of the tube was verified
with a fiberoptic bronchoscope. Controlled ventila-
tion was adjusted to maintain normocapnia (end
tidal CO2, 4.0 to 4.5 kPa) and to administer nitrous
oxide 50% in oxygen. A pulmonary artery catheter
was floated into the pulmonary artery with the can-
nulated right internal jugular vein. The patient was
placed in the right lateral decubitus position, and
two intrathecal catheters were placed in the second
and third lumbar intervertebral spaces. Continuous
and unlimited cerebral spinal fluid drainage was per-
formed throughout the procedure and for at least 24
hours after surgery to keep the CSF pressure lower
than 10 mm Hg. Routine anesthetic monitoring for
main vascular surgery was performed and stored on
disk every 30 seconds (Datex, Helsinki, Finland). 
Technique of transcranial motor evoked poten-
tial and somatosensory evoked potential record-
ing. Before surgery, custom-made disc electrodes of
a silver copper alloy, with diameters of 25 mm and
filled with conduction paste, were attached to the
skull. To improve electrode stability, gauze pads were
fixed over the discs with collodion. Both disc elec-
trodes were connected to a multipulse electrical stim-
ulator D 185 (Digitimer Ltd, Welwyn Garden City,
United Kingdom). Multipulse electrical stimulation
was applied with the anode at the vertex (Cz) and
with the cathode at the Fpz position (International
10-20 system for the placement of the electroen-
cephalogram electrodes). The trains, made of six puls-
es, were spaced apart for 2 ms and triggered from a
personal computer (PC) every minute. The output
voltage was set at 490 V, pulse duration 50 m s. To
monitor the level of neuromuscular blockade, the
right median nerve was supramaximally stimulated
every 20 seconds in a train of four mode with a gen-
eral evoked response stimulator (SMP 3100, Nihon,
Kohden, Japan) triggered by a PC. The electromyo-
graphic response was recorded from the thenar emi-
nence. Standard silver-chloride disc electrodes filled
with conduction paste were placed on the motor
points of those muscles. The myogenic potentials
were recorded on a timebase of 150 ms, passing
through a bandpass filter of 50 Hz to 500 Hz and
amplified 10,000 times (Neurotop, Nihon Kohden).
The signals were sampled at 1 kHz, digitized with a
12-bit analog-to-digital converter, and displayed on a
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standard PC screen. The amplitude was measured as
the voltage from the most negative component to the
most positive component of the evoked electromyo-
graphic activity (tcMEP). TcMEPs were measured
every 5 minutes before, during, and after cross clamp-
ing. Scalp SEP monitoring was obtained with 2-Hz
alternating stimulation of the posterior tibial nerve at
the ankle and the median nerve at the wrist, both on
the right side of the patient. Each minute, both wave-
forms, (ie, a result of a moving average of 128 stim-
uli) were presented on a PC screen as described.4 For
quantification of the SEP data, a power spectrum of
those waveforms was computed, starting 6 ms just
after the stimulation artefact over a timespan of 128
ms. The power spectrum between 20 and 80 Hz was
considered to be a significant part of the frequency
domain of both responses. Next, the root mean
square value was calculated within the chosen filter-
band of both spectra, resulting in a mean amplitude
(m V) of each response.
For neurophysiologic evaluation, the tibial nerve
SEP amplitude was presented as a percentage of the
median nerve SEP amplitude. If this percentage
decreased, lower extremity SEP loss was considered
as a consequence of spinal ischemia.
Surgical technique. A posterolateral thoracoto-
my in the fifth or sixth intercostal space was per-
formed, extending in a median laparotomy after arcus
costae transsection. Simultaneously, the left common
femoral artery was dissected free. After the opening of
the pericardium, the left atrium and left femoral artery
were cannulated and connected to the Biomedicus
(QRS, Velzen, The Netherlands) pump and bypass
grafting commenced. The mean proximal arterial
pressure was maintained between 60 and 100 mm
Hg, and the mean distal arterial line pressure was
maintained at higher than 60 mm Hg with the adjust-
ment of bypass flows and intravascular volume and
with nitroprusside infusion. Spontaneous hypother-
mia on bypass was tolerated (32°C to 34°C, as mea-
sured with rectal probe). If aneurysm configuration
allowed to do so, staged clamping was used to maxi-
mize the beneficial effect of the distal perfusion by the
left-heart bypass. After incision of the aneurysm, large
intercostal arteries localized within the aneurysm were
temporarily occluded with a balloon catheter. A
Dacron graft vascular prosthesis (Sigma Medical,
Apeldoorn, The Netherlands) was used. In all the
patients, the proximal anastomosis was created first.
After the testing of this anastomosis, major intercostal
arteries, especially between T-8 and L-2, were reim-
planted in the prosthesis and reperfused. In addition,
when marked tcMEP changes occurred after a few
minutes of the exclusion of the particular aneurysmal
segment, the intercostal arteries within this aortic seg-
ment were considered critical to the spinal circulation
and promptly reattached to that particular aortic seg-
ment. Rewarming to a rectal temperature of 36°C to
37°C was done while the distal anastomosis was being
performed and after reperfusion of all reimplanted
intercostal and lumbar vessels. After the termination
of the left-heart bypass, blood was retransfused into
the left atrium whenever possible. The cleaned
aneurysm wall was closed over the graft for addition-
al protection.
S-100 protein determination. CSF (2 to 3
mL) used in the measurement of S-100 protein was
drawn after induction of anesthesia and hemody-
namic stabilization, during the cross-clamp period of
the critical aortic segment, after 5 minutes of reper-
fusion of this segment, during the closure of the
skin, and 24 hours after closure of the skin.
The S-100 protein was determined with a com-
mercially available, two-site, immunoradiometric
assay kit (Sangtec Medical, Bromma, Sweden) accord-
ing the manufacturers instructions. The detection
limit for the kit was 0.2 m g·L-1. The S-100 protein
concentration seemed to be non-Gaussian distributed
and was expressed as median values (with 25th and
75th percentiles). Furthermore, the area under the
curve of the S-100 protein was calculated to estimate
the total amount of S-100 protein release.
Statistical analysis. The median amplitude from
four successive tcMEPs obtained from the tibialis
anterior muscle and the median value of 20 SEPs
(percent), both covering a time span of 20 minutes,
were calculated off line. Evoked potential changes (in
percent to baseline values), the number of intercostals
reimplanted or oversewn, and the changes in concen-
trations of S-100 protein were correlated (on the basis
of the Pearson correlation coefficient). The correla-
tions were corrected for potential confounders, such
as age and cross-clamp time. A P value of less than .05
was considered significant.
RESULTS
Good quality of tcMEP and SEP monitoring
during surgery could be accomplished except in
three patients because of technical problems (no
SEP monitoring). During aortic cross clamping, the
mean core body temperature was 32.1°C ± 0.4°C
and the mean proximal and distal perfusion pressure
was more than 60 mm Hg. None of the patients
died in the operating theater. The in-hospital mor-
tality rate was 15.8% (three of 19 patients). The
causes of death were cardiac failure (this patient
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showed paraplegia), bronchopneumonia resulting in
fulminating septicemia with multiple organ failure,
and postoperative retrograde dissection.
Table I shows the median values with 25th and
75th percentiles of S-100 protein concentration in
CSF. The patient with postoperative paraplegia is
listed separately. We observed increased concentra-
tions of S-100 protein during the procedure—the
highest in the CSF sample taken after 5 minutes of
reperfusion. The concentration of S-100 protein in
the CSF sample taken at the end of the procedure
and 24 hours after the repair decreased in all the
patients, except in the patient who was paraplegic.
We divided the patients into two groups. The
first group consisted of nine patients, who had a
concentration of S-100 protein in the CSF sample
taken 5 minutes after reperfusion that was two times
higher than the baseline value. In the second group
(10 patients), the concentration of S-100 protein in
this CSF sample showed a less than two times
increase than the baseline value. Table II shows the
S-100 protein concentrations at the different sam-
pling times in patients with and without a two-times
increase in S-100 protein concentration in the CSF
sample taken 5 minutes after reperfusion of the crit-
ical aortic segment. One of the nine patients in the
first group was diagnosed as having paraplegia. No
patient in the other group was paraplegic.
Table III shows the characteristics of the patients
without marked changes in evoked potential moni-
toring during the surgical procedure and who had
less increase in S-100 protein concentration in CSF
from baseline as compared with the characteristics of
patients with marked neurophysiologic changes.
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Table I. Median value (with 25th and 75th per-
centile) of S-100 protein concentration (m g/L) in
cerebrospinal fluid
All patients, Patient
except patient with
Cerebrospinal with postoperative postoperative
fluid paraplegia (n = 18) paraplegia (n = 1)
Sample 1 1.57 (1.16–2.04) 1.23
Sample 2 2.18 (1.37–4.16) 3.16
Sample 3 2.90 (2.00–7.07) 5.96
Sample 4 3.01 (1.91–4.75) 6.05
Sample 5 2.01 (0.95–3.59) 10.03
Sample 1, After hemodynamic stabilization; sample 2, during
clamping of critical aorta segment; sample 3, after 5 minutes of
reperfusion; sample 4, during closure of skin; sample 5, 24 hours
after closure of skin. 
Table III. Patient characteristics
Variable* Group 1 (n = 9) Patient with paraplegia Group 2 (n = 10)
Age (years) 63.6 ± 13.5 72 69.6 ± 6.7
Sex (%) 1 F (11), 8 M (89) M 2 F (20), 8 M (80)
Paraplegia (%) 1 (11) — 0 (0)
Cross-clamp time (minutes) 168 ± 47 185 131 ± 53
Area under the curve, S-100 protein 6612 ± 4290 10,571 3410 ± 1792
Number of reattached intercostals 3.8 ± 2.3 4 4.5 ± 3.5
Number of oversewn intercostals 3.1 ± 2.9 3 2.7 ± 2.9
tcMEP amplitude during cross clamping (percent from baseline) 44 ± 33 55 107 ± 51
tcMEP amplitude after 5 minutes of reperfusion (percent from baseline) 52 ± 46 90 132 ± 62
SEP during cross clamping (percent from baseline) 76 ± 35 99 86 ± 27
SEP after 5 minutes of reperfusion (percent from baseline) 80 ± 41 80 113 ± 38
Group 1, >200% increase in S-100 protein concentration in cerebrospinal fluid 5 minutes after reperfusion; group 2, <200% increase in
S-100 protein concentration in cerebrospinal fluid 5 minutes after reperfusion; tcMEP, transcranial motor evoked potential.
*Mean value ± standard deviation.
Table II. Median value (with 25th and 75th per-
centile) of S-100 protein concentration (m g/L) in
cerebrospinal fluid at different sampling times in
patients with (group 1) and without (group 2)
two-times increase in S-100 protein concentration
in cerebrospinal fluid sample taken 5 minutes after
reperfusion of critical aortic segment
Cerebrospinal fluid Group 1 (n = 9) Group 2 (n = 10)
Sample 1 1.43 (1.01–1.99) 1.62 (1.23–2.18)
Sample 2 2.10 (1.33–3.83) 2.28 (1.47–4.13)
Sample 3 5.96 (2.68–7.92) 2.10 (1.71–5.03)
Sample 4 3.59 (2.32–5.93) 2.83 (1.55–4.75)
Sample 5 1.55 (0.82–5.47) 2.43 (1.25–3.59)
Sample 1, After hemodynamic stabilization; sample 2, during
clamping of critical aorta segment; sample 3, after 5 minutes of
reperfusion; sample 4, during closure of skin; sample 5, 24 hours
after closure of skin. 
The patient with paraplegia showed a 45% reduc-
tion in tcMEP amplitude as compared with baseline
and no SEP changes during cross clamping. This
patient showed increased concentration of S-100
protein in CSF at the end of the surgical procedure
and after 24 hours. The patients, who had an intra-
operative change in tcMEPs, demonstated no signif-
icant difference in postoperative S-100 protein con-
centration as compared with the patients who had
no intraoperative change in their tcMEPs.
No significant correlation was found between the
S-100 protein concentrations (percent to baseline) in
the CSF samples and the cross-clamping time.
In Table IV, the correlations between the changes
in motor evoked potentials, the S-100 protein con-
centrations (percent to baseline) in the CSF samples,
and the calculated area under the curve of S-100 pro-
tein are listed, respectively. The negative correlations
mean that the tcMEP amplitudes were decreasing as
the S-100 protein was increasing. The changes in S-
100 protein concentration in CSF during surgery
were significantly correlated with the reduction in
tcMEP amplitude, especially during the cross-clamp
period. Table V shows a moderate to good correlation
between the number of reattached intercostals and
the S-100 dynamics in CSF during surgery. The best
negative correlation was found between the number
of intercostals reattached and the S-100 protein ele-
vation in the CSF sample drawn during closure of the
skin. Furthermore, this table also shows the correla-
tions between the tcMEP amplitude and the number
of reattached intercostals. A positive (r = 0.58; P =
.05) correlation was found between the change in
tcMEP amplitude during clamping and the number
of reattached intercostals. No significant correlation
was found between the SEP results, oversewn or reat-
tached intercostals (r < 0.20; P > .5), and the S-100
dynamics in CSF (r < –0.20; P > .5). The MEP
changes were not correlated with the SEP changes.
DISCUSSION
The results of this study show that the highest
concentration of S-100 protein was found in the CSF
sample taken 5 minutes after reperfusion. The
increased CSF S-100 protein after unclamping may
indicate the continuous release of S-100 protein from
ischemic neural tissue and may serve as a predictor of
reversible or irreversible spinal cord damage. S-100
protein is an acidic, calcium-binding protein with a
molecular weight of 21 kd synthetized in astroglial
cells in all parts of the central nervous system.6,7,9
Earlier results show that the CSF S-100 protein con-
centrations were always higher than those in the
blood, indicating its limited clearance through the
JOURNAL OF VASCULAR SURGERY
Volume 30, Number 2 van Dongen et al 297
Table IV. Correlations (controlled for clamp time and age) between changes in transcranial (motor)
evoked potentials (tcMEP in percent from baseline) during and 5 minutes after cross-clamp release and the
S-100 protein concentration in cerebrospinal fluid (in percent from baseline, sample 1; n = 19)
Amplitude tcMEP during clamping Amplitude tcMEP after 5 minutes of reperfusion
S-100 protein concentration
Sample 2 –0.67 (P = .018) –0.26 (P = .29)
Sample 3 –0.73 (P = .007) –0.35 (P = .15)
Sample 4 –0.67 (P = .017) –0.18 (P = .48)
Sample 5 –0.13 (P = .69) 0.11 (P = .65)
Area under the curve, S-100 0.11 (P = .68) –0.19 (P = .45)
tcMEP, Transcranial motor evoked potential; sample 1, after hemodynamic stabilization; sample 2, during clamping critical aorta segment;
sample 3, after 5 minutes of reperfusion; sample 4, during closure of skin; sample 5, 24 hours after closure of skin.
Table V. Correlations (controlled for clamp time
and age) between S-100 protein concentration in
cerebrospinal fluid (in percent from baseline, sample
1) and number of reattached intercostals and corre-
lations (controlled for clamp time and age) between
changes in amplitude of transcranial motor evoked
potentials (transcranial motor evoked potential in
percent from baseline) and number of reattached
intercostals (n = 19)
No. of reattached
intercostals
S-100 protein concentration
Sample 2 –0.53 (P = .078)
Sample 3 –0.59 (P = .044)
Sample 4 –0.66 (P = .02)
Sample 5 –0.41 (P = .19)
Area under the curve, S-100 –0.34 (P = .19)
Amplitude tcMEP during clamping 0.58 (P = .049)
Amplitude tcMEP after 5 minutes of reperfusion 0.11 (P = .73)
Sample 1, After hemodynamic stabilization; sample 2, during
clamping critical aorta segment; sample 3, after 5 minutes of
reperfusion; Sample 4, during closure of the skin; sample 5, 24
hours after closure of the skin; tcMEP, transcranial motor evoked
potential.
intact blood brain barrier.8 Several biochemical
events occur during the period of ischemia and reper-
fusion. In vitro and in vivo experiment results
showed that S-100 protein in lower (nanomolar)
concentrations act on glial and neuronal cells as a
growth-differentiating factor (suggesting that its ele-
vation may be a compensatory response), but higher
concentrations (micromolar) of S-100 protein reflect
or induce apoptosis.7 Apoptosis is a morphologically
distinct form of programmed cell death, with the
activation of a genetic program and changes that
indicate active protein synthesis preceding cell death.
It may have a role in the contribution of the patho-
logic changes in the ischemic and postischemic
hypoperfused spinal cord.13 Under pathologic condi-
tions in high concentrations, S-100 protein may act
from outside the cell, inducing death via apoptosis to
the target cell motoneurons. In experimental studies,
however, the addition of S-100 protein to chick
embryos in ovo during the period of naturally occur-
ring motor neuron cell death resulted in a significant
increase in motor but not sensory neuron survival.14
The cause of spinal cord injury during TAAA
surgery is multifactorial. Many factors, such as throm-
bosis, embolization of the intercostal arteries during
the surgical procedure, hypoperfusion of the spinal
cord during aortic cross clamping, and reperfusion
injury, could be responsible for the occurrence of para-
plegia or paraparesis. Furthermore, the extent of the
thoracoabdominal aortic aneurysm repair, the pres-
ence of dissection or rupture, the age of the patient,
postoperative hypotension, and a history of smoking
were independent predictors of paraplegia. TcMEP
and SEP recording is an on-line monitoring device
that enables the surgical team (ie, surgeon, anesthesi-
ologist, and neurophysiologist) during surgery to
identify situations in which spinal cord ischemia is like-
ly to occur. This study shows that tcMEP changes have
a better correlation with the S-100 protein release in
CSF than do SEP changes. The impulses that generate
SEPs in humans travel along large ascending myelinat-
ed fibers in the posterior columns of the spinal cord
(ie, the white matter at risk in this type of surgery).
The SEP data suggest that the impulses responsible for
the SEP arrive without any reduction at the synapse in
the posterior column nuclei at the cervicomedullary
junction. The impulses that generate MEPs descend in
the anterior cord, that is the white matter at risk, along
fast conducting large fiber-pyramidal neurons. It is
assumed that those motorpathways have monosynap-
tic connections with alpha motoneurons in the grey
matter of the spinal cord. At this level of the motoneu-
ron pool, postsynaptic potentials arise and summate to
cause alpha motoneurons to fire. The SEP data sug-
gest that the conductive capabilities of the large fibers
are not affected and, most likely, those of the motor
pathways are affected neither. Probably the reduction
in the MEP is a consequence of synaptic failure in the
grey matter, which cause less motounits to generate
the tibialis muscle response. This can be understood
on the fact that the metabolic rate of the grey matter
exceeds the metabolic rate of the white matter.15
During spinal cord ischemia, as revealed by the tcMEP
reductions in this study, the affected areas with
motoneurones may have biochemical changes sugges-
tive for apoptosis. The subsequent steep rise in S-100
protein concentration in CSF after reperfusion reflects
that apoptotic features may contribute to motoneuron
cell death after spinal cord ischemia.
These data show that the reattachment of inter-
costals seems to lower the S-100 protein release in
CSF, presuming a positive effect to the spinal cord
circulation at that moment and suggesting a
decreased spinal cord vulnerability in the first post-
operative days. Our data substantiate the reimplan-
tation of intercostal or lumbar arteries on a bio-
chemical and neurophysiologic base. It is our policy
to reimplant all the major intercostal arteries
between T8 and L-2, at least if technically feasible.
Reattachment of intercostal arteries may reduce the
impact of hemodynamic instability on the spinal
cord during operation and thereafter but may lead
to a longer cross-clamp time. Safi et al16 reported
the relationship between lower thoracic intercostal
artery ligation and neurologic deficit in a small
group of patients. In this study, no correlation was
found between the S-100 dynamics and the number
of oversewn intercostal arteries. These intercostals
were often small, calcified, and technically difficult
to reimplant. These arteries were probably not
important patent feeders of the spinal cord.
TcMEP and SEP monitoring can be effective in
the detection of spinal cord ischemia during TAAA
surgery and can be a physiologic guide in perform-
ing interventions to restore spinal cord perfusion
during a constant anesthetic regimen. An interpreta-
tion of the paraplegic case is that the tcMEP moni-
toring informed us of an intact motor pathway at the
end of the operation. During surgery, a rough visu-
al analysis revealed no sudden marked tcMEP
change. More detailed off-line analysis, however,
showed a gradual tcMEP reduction of maximal 45%
as compared with the baseline. Most likely, the con-
centration of S-100 protein in CSF 5 minutes after
reperfusion and during closure of the skin revealed a
borderline area of ischemia in the spinal cord.
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Thrombosis in the intercostal arteries or an ongoing
reperfusion injury (delayed onset paraplegia) already
starting in the operating room was probably respon-
sible for the spinal cord injury.8
An early sensitive marker of spinal cord damage
could be useful in the prevention of an eventual fur-
ther deterioration of spinal cord ischemia during and
after aortic repair. We have shown that in the patients
without paraplegia the S-100 protein concentrations
in CSF declined after unclamping. Further research
into reducing the deleterious effects of ischemia and
reperfusion injury to the spinal cord at the cellular
level is necessary to develop more protective tech-
niques. Brock et al17 suggested that elevated excita-
tory amino acid (glutamate, aspartate, glycine) levels
in CSF were associated with spinal cord ischemia.
Drenger et al18 reported the use of continuous CSF
lactate measurements as a possible predictor of an
adverse outcome.
Most of delayed onset paraplegia is related to a
period of postoperative hypotension as the result of
cardiorespiratory failure. The S-100 protein concen-
tration in CSF, especially during the cross-clamp peri-
od and 5 minutes after reperfusion, could be a bio-
chemical marker to detect the patient at risk for spinal
cord injury in the first postoperative hours or postop-
erative days. A disadvantage of S-100 protein analysis
is its time-consuming character, because it takes at
least 2 hours to run the analysis. Unfortunately, an
on-line determination of a biochemical marker is not
available—yet. S-100 protein analysis could be used
to retrospectively validate the effects of measures to
reduce neurologic deficits as, for instance, pharmaco-
logic interventions.
In conclusion, our findings show a correlation
between an increasing concentration of S-100 protein
in CSF and a reduction in MEP amplitude during
cross clamping of the aorta. A significant elevation of
CSF S-100 protein concentrations during TAAA
surgery may be an early sensitive indicator of spinal
cord ischemia and, as suggested in this study, warrants
tcMEP monitoring on the intensive care unit to
detect and prevent further neurologic deficits. Evoked
potential monitoring may be a method to evaluate the
hemodynamic measures to protect the spinal cord in
the postoperative period as well. Hypotension and
low flow states should be aggressively avoided and
treated. Further study is necessary on a larger group
of patients to correlate the dynamics of S-100 protein
in CSF with the neurophysiologic recordings and to
confirm whether tcMEP and SEP monitoring can
support spinal cord protective techniques in reducing
adverse neurologic outcome.
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